<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Stem Cell Investig</journal-id>
<journal-id journal-id-type="iso-abbrev">Stem Cell Investig</journal-id>
<journal-id journal-id-type="publisher-id">SCI</journal-id>
<journal-title-group>
<journal-title>Stem Cell Investigation</journal-title>
</journal-title-group>
<issn pub-type="ppub">2306-9759</issn>
<issn pub-type="epub">2313-0792</issn>
<publisher>
<publisher-name>AME Publishing Company</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28815173</article-id>
<article-id pub-id-type="pmc">5539390</article-id>
<article-id pub-id-type="publisher-id">sci-04-2017.06.10</article-id>
<article-id pub-id-type="doi">10.21037/sci.2017.06.10</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Mouse models and induced pluripotent stem cells in researching psychiatric disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Deng</surname>
<given-names>Bowei</given-names>
</name>
</contrib>
<aff id="aff1">Masters of Science in Biomedical Sciences Program, <institution>Tufts University School of Medicine</institution>, <addr-line>Boston, Massachusetts</addr-line>, <country>USA</country></aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><italic>Correspondence to:</italic> Bowei Deng. Masters of Science in Biomedical Sciences Program, Tufts University School of Medicine, Boston, Massachusetts, USA. Email: <email xlink:href="bowei.deng@tufts.edu">bowei.deng@tufts.edu</email>.</corresp>
<fn fn-type="COI-statement">
<p><italic>Conflicts of Interest:</italic> The author has no conflicts of interest to declare.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>17</day>
<month>7</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>4</volume>
<elocation-id>62</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>5</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>25</day>
<month>5</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>2017 Stem Cell Investigation. All rights reserved.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Stem Cell Investigation.</copyright-holder>
</permissions>
<abstract>
<p>Psychiatric disorders are a problem for society both on a micro level involving patients and their families as well as on a macro level involving global economic costs. For years, scientists have relied on mouse models for research, but these have shortcomings that greatly hinder efforts to understand the pathophysiology and genetic factors of psychiatric disorders. Induced pluripotent stem cells (iPSCs) have shown potential to overcome obstacles that mouse models face and can provide patient-specific cells that allow for better understanding of genetic effects on psychiatric disorders. This review explores the current progress using iPSCs to model psychiatric disorders, specifically bipolar disorder and schizophrenia, while discussing remaining issues with iPSC use and how these issues can be resolved in the future.</p>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords: </title>
<kwd>Mouse models</kwd>
<kwd>induced pluripotent stem cell</kwd>
<kwd>psychiatric disorders</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>